WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.
about
Cognitive neuropsychology of HIV-associated neurocognitive disordersAntidepressants for depression in adults with HIV infectionPreservation of cognitive and musical abilities of a musician following surgery for chronic drug-resistant temporal lobe epilepsy: a case report.Pattern of neuropsychological performance among HIV positive patients in Uganda.Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais.What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review.HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda.HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot studyComponents of depression in HIV-1 infection: their differential relationship to neurocognitive performance.Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, BotswanaAdverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young AdultsNeuropsychiatric manifestations of HIV infection and AIDSNeurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.A low cortisol response to acute stress is related to worse basal memory performance in older people.Treatment of depression in HIV-infected patients.Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural ChinaWhat is the role of the HIV liaison psychiatrist?Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS.HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya.HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.Neurocognitive impairments in hiv infection.Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load.Symptoms of common mental disorder and cognitive associations with seropositivity among a cohort of people coming for testing for HIV/AIDS in Goa, India: a cross-sectional survey.HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.Neurology and the Global HIV Epidemic.Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western KenyaPrevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern NigeriaScreening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shiftingSocioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort.Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV.HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia.International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271.Addition of home-based cognitive retraining to treatment as usual in first episode schizophrenia patients: a randomized controlled studyCross-cultural adaptation and validation of the self-reporting questionnaire among HIV+ individuals in a rural ART program in southern Uganda.A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settingsClinical care of the HIV-infected drug user
P2860
Q22252615-4AAD88C5-3342-4B11-935F-30CDFBB43E79Q24235613-93AF3C69-924D-4031-9618-2B06A1E1AA51Q30390036-23C65A18-77E4-477F-B83B-FDBB7A4F8607Q30445074-DE9CF7A3-B051-44BB-960D-4E1A415592AFQ30879194-FAD505B5-D687-4DBA-87F7-B478D7201A11Q33570869-32EC8094-2001-4144-AF22-D0B01C199691Q33624877-8D7E277E-068D-4CE8-8309-BDA69EA7F909Q33631688-4B18B893-E67C-4382-B0F7-DB07985B1D7CQ33801157-C5CBEC24-61CC-4F73-9DD8-117677389F22Q33827642-A8DF3825-639A-4E7B-B390-2ADB3B5EF6D3Q33834140-B3557D7F-4C26-4B7F-AC01-23860C156628Q33849832-10414694-EA36-4C9F-9773-C4E94351B7D8Q33868874-019AEB70-E7EB-4242-A651-9DF39ABAEC6FQ33875335-82B691E6-7401-4F86-BC34-5D678EE4B0B1Q33890060-B4720565-798C-411D-B9D0-28DDDBDDECE0Q33894714-0FA2A312-AA74-4EEE-A652-9E8BEE1742D9Q33901326-DDD23849-3F0B-4CC0-98E6-FC16E045B243Q33922144-0CF71CFA-7B04-4BE8-B292-DF216E0F44C1Q33927844-D3E9FB88-B35C-4D1D-AC58-08D2432C8558Q33937129-F12081C2-C63D-488B-B539-A5A5E3FA56BBQ34024194-F801AD22-579A-4A8A-8130-297365B1AA0EQ34135328-61F1E278-1C13-42F5-8D00-0D96573D8AD8Q34193503-5FDDF8AC-20DD-4263-BC0D-23BFD85E9E90Q34221268-17FAF159-F03F-43A6-8DA3-231A5C732D48Q34231209-8FF76CAF-2A5D-459E-BDD8-FDFD8A9664D9Q34324910-3127BF76-7DA5-4315-B458-C8DA2A20CF85Q34623219-5F6C67A9-69B7-4B15-8FA9-1A307044CCEEQ34922069-62C14CB7-7D24-4351-8961-9718BCCB64F7Q35149362-5FBAC023-355C-45E7-80FD-221DD08B86ACQ35195299-6FF96F10-7625-48BB-89FF-B8B15053F61DQ35498551-F1D5C792-B23B-4E5B-A063-09011EEF3468Q35533317-66A7E7D9-9B68-4B59-9BB7-F966D8B7CBE1Q35647138-DF0BFEA8-CAAA-485B-91C1-E5D0D54AE3ABQ35750352-AA2A218E-0049-435C-B454-45BF93A5F4ABQ35856810-10A14415-4EA1-45F4-BFCF-CB8E2344625AQ35886270-3DE4400A-4F06-41C7-AF91-3BCE7E433F30Q35919571-5F8533C7-CFBE-490C-9D88-45FA573E0B11Q35939700-C68E918E-3E62-4AEF-9074-CD4CD67B93DCQ35993860-3BD876AB-CD0B-46C1-BA04-B3451DE6B50CQ36248580-7076FEB2-A310-4276-9E0F-EC126EF52E8D
P2860
WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@en
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@nl
type
label
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@en
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@nl
prefLabel
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@en
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@nl
P2093
P1433
P1476
WHO Neuropsychiatric AIDS stud ...... cal and neurological findings.
@en
P2093
Sughondhabirom B
P356
10.1001/ARCHPSYC.1994.03950010051007
P407
P577
1994-01-01T00:00:00Z